SGRY
Surgery Partners Inc
14.20$
-2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.1% | -2.4% | +6.2% | +1.1% | +12.2% | -10.2% | +6.5% | -0.6% | +7.7% | -8.4% | +4.7% | – | |
| – | +6.6% | +3.7% | +3.7% | +1.7% | +6.4% | -2.6% | +2.7% | -0.7% | +7.4% | +2.4% | -4.4% | – | |
| – | +16.8% | -19.8% | +15.4% | -0.9% | +31.6% | -30.7% | +20.8% | -0.2% | +8.7% | -42.6% | +56.3% | – | |
| – | -43.2% | +58.9% | +21.4% | -27.5% | +23.3% | +0.0% | +0.3% | +797.0% | -60.8% | +10.9% | -74.2% | – | |
| – | +10.8% | -14.0% | +19.0% | +23.5% | -8.7% | -6.1% | -16.1% | +6.8% | +13.8% | -61.5% | +124.2% | – | |
| – | +22.8% | -25.0% | +11.6% | -28.2% | +108.7% | -51.3% | +80.5% | -5.4% | +4.3% | -25.2% | +23.9% | – | |
| – | -2.2% | -2.9% | +8.9% | -2.9% | +5.8% | +17.6% | +9.2% | +393.5% | -42.5% | -63.4% | -1.0% | – | |
| – | +60.7% | -45.5% | +16.0% | -67.3% | +580.7% | -100.4% | – | -29.7% | +38.3% | -107.7% | – | – | |
| – | +93.5% | -26.7% | +11.4% | -8.2% | +2,584.4% | -69.0% | -102.9% | – | +147.3% | -108.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.8% | -17.2% | +9.0% | -7.1% | +44.9% | -39.0% | +54.8% | +166.7% | -27.2% | -64.2% | +33.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.